Per Eriksson
About
In The Last Decade
Per Eriksson
394 papers receiving 18.6k citations
Hit Papers
Peers
Comparison fields: 5 of 185
- Molecular Biology 5.4k
- Cancer Research 3.5k
- Pulmonary and Respiratory Medicine 3.2k
- Cardiology and Cardiovascular Medicine 3.1k
- Epidemiology 3.1k
Countries citing papers authored by Per Eriksson
This map shows the geographic impact of Per Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Eriksson more than expected).
Fields of papers citing papers by Per Eriksson
This network shows the impact of papers produced by Per Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Eriksson. The network helps show where Per Eriksson may publish in the future.
Co-authorship network of co-authors of Per Eriksson
This figure shows the co-authorship network connecting the top 25 collaborators of Per Eriksson. A scholar is included among the top collaborators of Per Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Eriksson. Per Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | 10 | |
| 5 | 9 | |
| 6 | 9 | |
| 7 | Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe | 1 |
| 8 | 4 | |
| 9 | Comparison between Multiplex and Routine Clinical Immunology Analysis of Antibodies Against SSA and SSB | 1 |
| 10 | 1 | |
| 11 | 33 | |
| 12 | 16 | |
| 13 | 63 | |
| 14 | Gene Variants In Fam167A-Blk And Tnfsf4 Are Associated With Primary Sjogren'S Syndrome | 1 |
| 15 | Neurotoxicity of different polybrominated diphenyl ethers, including PBDE 209 | 1 |
| 16 | Co-exposure to a polybrominated diphenyl ether (PBDE 99) and an ortho-substituted PCB (PCB 52) enhances developmental neurotoxic effects | 8 |
| 17 | SKOGFORSK REVIEW OF SYSTEMS FOR LOGGING RESIDUES HANDLING IN SWEDEN | 5 |
| 18 | PBDE, 2,2',4,4'5-pentabromodiphenyl ether causes permanent neurotoxic effects during a defined period of neonatal brain development | 24 |
| 19 | Interactive effects of PCB and nicotine administered during the neonatal brain development | 3 |
| 20 | A vldl response element in the promoter region of the human pai-1 gene implicated in the impaired fibrinolysis of hypertriglyceridaemia | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.